Cancer vaccine effective for 60% of patients
60% of melanoma patients responded to universal cancer vaccine.
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
60% of melanoma patients responded to universal cancer vaccine.
We participated in the first digital NLSDays this week.
We participated in the influential technology conference SXSW2021.
OCC Accelerator will help start-ups in cancer innovation succeed.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.